Targeting mitochondria as therapeutic strategy for metabolic disorders

Daniela Sorriento, Antonietta Valeria Pascale, Rosa Finelli, Anna Lisa Carillo, Roberto Annunziata, Bruno Trimarco, Guido Iaccarino

Research output: Contribution to journalArticle

Abstract

Mitochondria are critical regulator of cell metabolism; thus, mitochondrial dysfunction is associated with many metabolic disorders. Defects in oxidative phosphorylation, ROS production, or mtDNA mutations are the main causes of mitochondrial dysfunction in many pathological conditions such as IR/diabetes, metabolic syndrome, cardiovascular diseases, and cancer. Thus, targeting mitochondria has been proposed as therapeutic approach for these conditions, leading to the development of small molecules to be tested in the clinical scenario. Here we discuss therapeutic interventions to treat mitochondrial dysfunction associated with two major metabolic disorders, metabolic syndrome, and cancer. Finally, novel mechanisms of regulation of mitochondrial function are discussed, which open new scenarios for mitochondria targeting.

Original languageEnglish
Article number604685
JournalTheScientificWorldJournal
Volume2014
DOIs
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Environmental Science(all)
  • Medicine(all)

Fingerprint Dive into the research topics of 'Targeting mitochondria as therapeutic strategy for metabolic disorders'. Together they form a unique fingerprint.

  • Cite this

    Sorriento, D., Pascale, A. V., Finelli, R., Carillo, A. L., Annunziata, R., Trimarco, B., & Iaccarino, G. (2014). Targeting mitochondria as therapeutic strategy for metabolic disorders. TheScientificWorldJournal, 2014, [604685]. https://doi.org/10.1155/2014/604685